Douglass Hanly Moir Pathology

Sonic Healthcare Pty Ltd

Site

Macquarie Park – Division of Toxicology

Accreditation No.

2178

Site No.

25722

Date of Accreditation

01 Jun 2017

Address

14-16 Giffnock Ave
Macquarie Park, NSW 2113
Australia

dhm.com.au

Contact

Ms Tuyen Chieu P: +61 (02) 98556042

Availability

Services available to external clients

Supervision

Not Applicable

Douglass Hanly Moir Pathology address map

Scope of Accreditation

Print scopes
Macquarie Park – Division of Toxicology

ISO/IEC 17025 (2017)

Human Testing for Workplace and/or Community Screening

Service Product Determinant Technique Procedure
Monitoring for residues, hydrocarbons and other contaminants of the environment (excluding pesticides) Urine 1-Hydroxypyrene; s-Phenyl mercapturic acid Triple Quad LC-MS-MS In-house procedure; NPAAC requirements for the development and use of in-house IVD's.

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Appendix A Additional and optional testing Urine 6-Acetylmorphine; Dihydrocodeine (6α-hydrocodol); Ecgonine methyl ester; Ephedrine; Fentanyl; Hydrocodone; Hydromorphone; Meperidine (pethidine); Norfentanyl; Oxycodone; Oxymorphone; Phentermine; Pholcodine; Propoxyphene; Pseudoephedrine (PSE); Thebaine; Tramadol
Diazepam
Medico legal drug testing AS/NZS 4308:2023, Section 2 Specimen collection, storage, handling and dispatch Urine Colour; Creatinine; Temperature; pH
Medico legal drug testing AS/NZS 4308:2023, Section 4 General laboratory requirements Urine General laboratory requirements as described in AS/NZS 4308
Medico legal drug testing AS/NZS 4308:2023, Section 5 Laboratory screening procedures Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Creatinine; Opiates; Tetrahydrocannabinol (THC) metabolites; Urea; pH
Medico legal drug testing AS/NZS 4308:2023, Section 6 Laboratory confirmatory procedures Urine 11-nor-9-carboxy-Δ9-Tetrahydrocannabinol; 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); Amphetamines; Benzoylecgonine (ecgonine benzoate); Codeine; Methylamphetamine; Morphine
7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Nordiazepam; Oxazepam; Temazepam; α-Hydroxyalprazolam
Medico legal drug testing AS/NZS 4760, Appendix B Additional testing Oral fluid Alprazolam; Clonazepam; Diazepam; Ecgonine methyl ester; Nitrazepam; Nordiazepam; Oxazepam; Temazepam
Benzodiazepines
Medico legal drug testing AS/NZS 4760, Section 2 Collection, storage, handling and dispatch Oral fluid Handling and dispatch; Sample collection and storage
Medico legal drug testing AS/NZS 4760, Section 3 General laboratory requirements Oral fluid General laboratory requirements as described in AS/NZS 4760
Medico legal drug testing AS/NZS 4760, Section 4 Laboratory screen testing Oral fluid Amphetamine type substances; Cocaine; Cocaine metabolites; Opiates; Δ-9-Tetrahydrocannabinol (THC-Δ9)
Medico legal drug testing AS/NZS 4760, Section 5 Laboratory confirmatory procedures Oral fluid 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Amphetamines; Benzoylecgonine (ecgonine benzoate); Cocaine; Codeine; Methylamphetamine; Morphine; Oxycodone; Δ-9-Tetrahydrocannabinol (THC-Δ9)

The only data displayed is that deemed relevant and necessary for the clear description of the Activities and Services covered by the Scope of Accreditation (SoA).

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.

The Product column may also describe an Item or Material.

The Limitations column may also describe the Range.